ARTICLE | Financial News
Precision BioSciences raises $110M in series B
June 26, 2018 7:46 PM UTC
Genome editing company Precision BioSciences Inc. (Durham, N.C.) raised $110 million in an oversubscribed series B round led by new investor ArrowMark Partners.
Other new Investors included Franklin Templeton, Cowen Healthcare Investments, Brace Pharma Capital, Pontifax AgTech, OCV Partners, Adage Capital Management, Cormorant Asset Management, Gilead Sciences Inc. (NASDAQ:GILD), Vivo Capital, Alexandria Venture Investments, Ridgeback Capital, Agent Capital and affiliates of Leerink...